RAPP – rapport therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Is Rapport Therapeutics Stock a Buy After Investment Firm Cormorant Raised Its Stake Over $60 Million? [Yahoo! Finance]
Rapport Therapeutics (NASDAQ:RAPP) was given a new $51.00 price target on by analysts at Wells Fargo & Company.
Rapport Therapeutics (NASDAQ:RAPP) had its "buy" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..
Rapport Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
Rapport Therapeutics (NASDAQ:RAPP) was upgraded by analysts at Wall Stre
Form 4 Rapport Therapeutics, For: Dec 17 Filed by: Ceesay Abraham
Form 144 Rapport Therapeutics, Filed by: Ceesay Abraham
Form 144 Rapport Therapeutics, Filed by: Ceesay Abraham
Form 4 Rapport Therapeutics, For: Dec 15 Filed by: Bredt David
Form 4 Rapport Therapeutics, For: Nov 26 Filed by: Gault Cheryl
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.